Chemclin Diagnostics Co., Ltd. (SHA:688468)
China
· Delayed Price · Currency is CNY 7.41
+0.17 (2.35%)
Apr 29, 2026, 3:00 PM CST
Chemclin Diagnostics Market Cap
Chemclin Diagnostics has a market cap or net worth of 2.92 billion as of April 29, 2026. Its market cap has decreased by -0.54% in one year.
Market Cap
2.92B
Enterprise Value
2.75B
Revenue
332.68M
Ranking
n/a
PE Ratio
67.36
Stock Price
7.41
Market Cap Chart
Since April 9, 2021, Chemclin Diagnostics's market cap has decreased from 10.00B to 2.92B, a decrease of -70.76%. That is a compound annual growth rate of -21.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 2.86B | -1.36% |
| Dec 31, 2025 | 2.90B | 7.15% |
| Dec 31, 2024 | 2.70B | -37.53% |
| Dec 29, 2023 | 4.33B | 13.94% |
| Dec 30, 2022 | 3.80B | -47.15% |
| Dec 31, 2021 | 7.19B | -28.15% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Berry Genomics Co.,Ltd | 3.45B |
| Shanghai Rendu Biotechnology | 2.35B |
| Medicalsystem Biotechnology | 3.71B |
| Shanghai Labway Clinical Laboratory | 3.78B |
| Guangdong Hybribio Biotech | 3.83B |
| Thalys Medical Technology Group | 4.48B |
| SMO ClinPlus CO.,LTD. | 4.51B |
| Cowealth Medical China | 6.19B |